|
G |
Aadat |
aminoadipate aminotransferase |
affects expression |
EXP |
Amitriptyline affects the expression of AADAT mRNA |
CTD |
PMID:18355885 |
|
NCBI chr16:29,509,392...29,544,332
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
decreases expression |
EXP |
Amitriptyline results in decreased expression of ABAT mRNA |
CTD |
PMID:21820738 |
|
NCBI chr10:7,503,351...7,599,474
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of ABCB11 mRNA |
CTD |
PMID:27765674 |
|
NCBI chr 3:74,424,620...74,520,646
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
affects transport increases transport affects expression |
ISO EXP |
ABCB1A protein affects the transport of Amitriptyline ABCB1A protein results in increased transport of Amitriptyline; ABCB1A protein results in increased transport of Amitriptyline metabolite Amitriptyline affects the expression of ABCB1 mRNA |
CTD |
PMID:10700657 PMID:12082591 PMID:18355885 |
|
NCBI chr 4:26,312,403...26,488,456
|
|
G |
Abcd2 |
ATP binding cassette subfamily D member 2 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of ABCD2 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 7:122,263,034...122,311,642
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of ABCG5 mRNA |
CTD |
PMID:27765674 |
|
NCBI chr 6:9,965,118...9,990,563
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of ABCG8 mRNA |
CTD |
PMID:27765674 |
|
NCBI chr 6:9,945,629...9,964,912
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
increases expression |
ISO |
Amitriptyline results in increased expression of ACE2 mRNA |
CTD |
PMID:32808185 |
|
NCBI chr X:30,293,597...30,340,961
|
|
G |
Ache |
acetylcholinesterase |
decreases expression increases activity |
EXP ISO |
Amitriptyline results in decreased expression of ACHE mRNA Amitriptyline results in increased activity of ACHE protein |
CTD |
PMID:21820738 PMID:29614332 |
|
NCBI chr12:25,042,882...25,050,608
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
affects expression |
EXP |
Amitriptyline affects the expression of ALDH1A1 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 1:218,000,470...218,152,962
|
|
G |
Ankrd1 |
ankyrin repeat domain 1 |
increases expression |
EXP |
Amitriptyline results in increased expression of ANKRD1 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 1:233,815,851...233,834,891
|
|
G |
Ano3 |
anoctamin 3 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of ANO3 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 3:97,235,671...97,550,090
|
|
G |
Ap1s1 |
adaptor related protein complex 1 subunit sigma 1 |
decreases expression |
ISO |
Amitriptyline results in decreased expression of AP1S1 mRNA |
CTD |
PMID:17175557 PMID:17567588 |
|
NCBI chr12:19,625,267...19,635,792
|
|
G |
Apoa4 |
apolipoprotein A4 |
affects expression |
EXP |
Amitriptyline affects the expression of APOA4 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 8:55,435,779...55,438,160
|
|
G |
Arg1 |
arginase 1 |
increases expression |
EXP |
Amitriptyline results in increased expression of ARG1 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 1:22,295,093...22,307,720
|
|
G |
Asah1 |
N-acylsphingosine amidohydrolase 1 |
increases expression |
ISO |
Amitriptyline results in increased expression of ASAH1 mRNA |
CTD |
PMID:15342952 PMID:17175557 PMID:17567588 |
|
NCBI chr16:57,669,927...57,701,349
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
increases expression |
ISO |
Amitriptyline results in increased expression of ASNS mRNA |
CTD |
PMID:15342952 PMID:17175557 PMID:17567588 |
|
NCBI chr 4:36,752,061...36,769,970
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
EXP |
Amitriptyline results in increased expression of ATF3 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr13:105,274,103...105,331,653
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
Amitriptyline inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein] |
CTD |
PMID:19135049 |
|
NCBI chr 1:105,076,472...105,081,906
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP |
Amitriptyline inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] |
CTD |
PMID:19135049 |
|
NCBI chr13:23,204,464...23,366,900
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
affects expression |
EXP |
Amitriptyline affects the expression of BHMT mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 2:26,594,852...26,614,429
|
|
G |
C1qa |
complement C1q A chain |
increases expression |
EXP |
Amitriptyline results in increased expression of C1QA mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 5:154,417,086...154,419,933
|
|
G |
C1qc |
complement C1q C chain |
increases expression |
EXP |
Amitriptyline results in increased expression of C1QC mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 5:154,410,845...154,414,208
|
|
G |
Cacna2d1 |
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
increases expression |
EXP |
Amitriptyline results in increased expression of CACNA2D1 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 4:19,902,324...20,330,287
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [7-ketocholesterol affects the localization of CASP1 protein]; Amitriptyline inhibits the reaction [7-ketocholesterol results in increased activity of CASP1 protein]; Amitriptyline inhibits the reaction [Cholesterol analog affects the localization of CASP1 protein]; Amitriptyline inhibits the reaction [Cholesterol analog results in increased activity of CASP1 protein] |
CTD |
PMID:28633109 |
|
NCBI chr 8:10,746,338...10,882,295
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity |
EXP |
Amitriptyline inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP3 protein] Amitriptyline results in increased expression of CASP3 mRNA Amitriptyline results in increased activity of CASP3 protein |
CTD |
PMID:16717317 PMID:19135049 PMID:19815060 |
|
NCBI chr16:52,395,539...52,413,794
|
|
G |
Casr |
calcium-sensing receptor |
decreases expression |
EXP |
Amitriptyline results in decreased expression of CASR mRNA |
CTD |
PMID:22341215 |
|
NCBI chr11:77,738,398...77,813,639
|
|
G |
Cat |
catalase |
decreases expression |
ISO |
Amitriptyline results in decreased expression of CAT protein |
CTD |
PMID:1937386 |
|
NCBI chr 3:110,297,340...110,329,526
|
|
G |
Cd74 |
CD74 molecule |
increases expression |
EXP |
Amitriptyline results in increased expression of CD74 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr18:54,256,757...54,266,003
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
affects expression |
EXP |
Amitriptyline affects the expression of CDKN2C mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 5:129,639,736...129,645,564
|
|
G |
Ces2h |
carboxylesterase 2H |
affects expression |
EXP |
Amitriptyline affects the expression of CES2 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr19:32,974,242...32,988,842
|
|
G |
Chat |
choline O-acetyltransferase |
increases expression |
EXP |
Amitriptyline results in increased expression of CHAT mRNA |
CTD |
PMID:21820738 |
|
NCBI chr16:7,657,362...7,717,093
|
|
G |
Chrna3 |
cholinergic receptor nicotinic alpha 3 subunit |
decreases expression |
EXP |
Amitriptyline results in decreased expression of CHRNA3 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 8:55,401,668...55,415,165
|
|
G |
Chrnb2 |
cholinergic receptor nicotinic beta 2 subunit |
decreases expression increases response to substance |
EXP ISO |
Amitriptyline results in decreased expression of CHRNB2 mRNA CHRNB2 protein results in increased susceptibility to Amitriptyline |
CTD |
PMID:21820738 PMID:21905669 |
|
NCBI chr 2:175,181,402...175,189,619
|
|
G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
affects expression |
EXP |
Amitriptyline affects the expression of CMTM6 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 8:114,422,934...114,441,034
|
|
G |
Cpne4 |
copine 4 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of CPNE4 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 8:105,177,376...105,653,075
|
|
G |
Cpped1 |
calcineurin-like phosphoesterase domain containing 1 |
affects expression |
EXP |
Amitriptyline affects the expression of CPPED1 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr10:3,701,522...3,821,050
|
|
G |
Crem |
cAMP responsive element modulator |
affects expression |
EXP |
Amitriptyline affects the expression of CREM mRNA |
CTD |
PMID:18355885 |
|
NCBI chr17:58,932,011...59,001,160
|
|
G |
Csrp3 |
cysteine and glycine rich protein 3 |
increases expression |
EXP |
Amitriptyline results in increased expression of CSRP3 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 1:98,528,067...98,546,647
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [7-ketocholesterol affects the localization of CYBB protein]; Amitriptyline inhibits the reaction [7-ketocholesterol analog affects the localization of CYBB protein] |
CTD |
PMID:28633109 |
|
NCBI chr X:16,030,596...16,065,065
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases metabolic processing multiple interactions |
ISO |
Amitriptyline results in increased metabolism of CYP1A2 protein; CYP1A2 protein results in increased metabolism of Amitriptyline [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Amitriptyline |
CTD |
PMID:18359012 PMID:23397584 PMID:27320963 |
|
NCBI chr 8:66,971,261...66,978,149
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
affects expression |
EXP |
Amitriptyline affects the expression of CYP2A1 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 1:82,231,611...82,244,887
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
EXP |
Amitriptyline results in increased expression of CYP2B1 mRNA |
CTD |
PMID:10945841 |
|
NCBI chr 1:90,646,098...90,669,762
|
|
G |
Cyp2b15 |
cytochrome P450, family 2, subfamily b, polypeptide 15 |
affects expression |
EXP |
Amitriptyline affects the expression of CYP2B15 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 1:82,094,188...82,106,492
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
Amitriptyline results in increased expression of CYP2B2 mRNA |
CTD |
PMID:10945841 |
|
NCBI chr 1:90,722,243...90,736,272
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases metabolic processing |
ISO |
CYP2B6 protein results in increased metabolism of Amitriptyline |
CTD |
PMID:27320963 |
|
NCBI chr 1:90,780,468...90,859,852
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
multiple interactions increases metabolic processing |
ISO |
[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Amitriptyline CYP2C19 protein results in increased metabolism of Amitriptyline |
CTD |
PMID:23397584 PMID:27320963 |
|
NCBI chr 1:247,879,058...247,916,804
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases activity multiple interactions increases metabolic processing |
ISO |
Amitriptyline results in decreased activity of CYP2D6 protein [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Amitriptyline Amitriptyline results in increased metabolism of CYP2D6 protein; CYP2D6 protein results in increased metabolism of Amitriptyline |
CTD |
PMID:16044105 PMID:18359012 PMID:18359183 PMID:23397584 PMID:27320963 |
|
NCBI chr 7:115,762,662...115,771,832
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing multiple interactions |
ISO |
Amitriptyline results in increased metabolism of CYP3A4 protein [CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to Amitriptyline |
CTD |
PMID:18359012 PMID:23397584 |
|
NCBI chr12:14,321,771...14,343,886
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression affects expression |
EXP |
Amitriptyline results in increased expression of CYP3A23-3A1 mRNA Amitriptyline affects the expression of CYP3A23-3A1 mRNA |
CTD |
PMID:10945841 PMID:18355885 |
|
NCBI chr12:14,369,950...14,398,803
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases metabolic processing |
ISO |
Amitriptyline results in increased metabolism of CYP3A5 protein |
CTD |
PMID:18359012 |
|
NCBI chr12:21,919,955...21,960,160
|
|
G |
Cyp4f4 |
cytochrome P450, family 4, subfamily f, polypeptide 4 |
affects expression |
EXP |
Amitriptyline affects the expression of CYP4F2 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 7:11,717,208...11,733,507
|
|
G |
Dcaf8 |
DDB1 and CUL4 associated factor 8 |
affects expression |
EXP |
Amitriptyline affects the expression of DCAF8 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr13:87,141,940...87,199,859
|
|
G |
Depp1 |
DEPP autophagy regulator 1 |
increases expression |
ISO |
Amitriptyline results in increased expression of DEPP1 mRNA |
CTD |
PMID:15342952 PMID:17175557 PMID:17567588 |
|
NCBI chr 4:149,910,794...149,913,013
|
|
G |
Des |
desmin |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [Homocysteine results in increased expression of DES protein] |
CTD |
PMID:23024785 |
|
NCBI chr 9:84,299,626...84,307,344
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
decreases activity |
EXP |
Amitriptyline results in decreased activity of DNMT1 protein Amitriptyline decreases activity of Dnmt1 protein in astrocyte nucleus |
CTD RGD |
PMID:19924110 PMID:22880885 |
RGD:9588218 |
NCBI chr 8:19,440,611...19,486,659
|
|
G |
Drd1 |
dopamine receptor D1 |
increases expression |
EXP |
Amitriptyline results in increased expression of DRD1 mRNA |
CTD |
PMID:16499906 |
|
NCBI chr17:10,545,488...10,550,029
|
|
G |
Drd3 |
dopamine receptor D3 |
increases expression |
EXP |
Amitriptyline results in increased expression of DRD3 mRNA |
CTD |
PMID:21820738 |
|
NCBI chr11:70,385,586...70,437,793
|
|
G |
Ecel1 |
endothelin converting enzyme-like 1 |
increases expression |
EXP |
Amitriptyline results in increased expression of ECEL1 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 9:95,267,417...95,276,508
|
|
G |
Eif4b |
eukaryotic translation initiation factor 4B |
affects expression |
EXP |
Amitriptyline affects the expression of EIF4B mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 7:135,085,259...135,107,054
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
affects expression |
EXP |
Amitriptyline affects the expression of EPHX1 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr13:95,246,079...95,275,852
|
|
G |
Erp29 |
endoplasmic reticulum protein 29 |
affects expression |
EXP |
Amitriptyline affects the expression of ERP29 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr12:40,750,177...40,756,607
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
increases expression |
ISO |
Amitriptyline results in increased expression of FABP1 mRNA |
CTD |
PMID:15342952 PMID:17175557 PMID:17567588 |
|
NCBI chr 4:104,744,302...104,753,119
|
|
G |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
increases expression |
EXP |
Amitriptyline results in increased expression of FLRT3 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 3:127,994,491...128,008,137
|
|
G |
Fmo3 |
flavin containing dimethylaniline monoxygenase 3 |
increases metabolic processing |
ISO |
FMO3 protein results in increased metabolism of Amitriptyline |
CTD |
PMID:27320963 |
|
NCBI chr13:75,309,367...75,334,915
|
|
G |
Fndc4 |
fibronectin type III domain containing 4 |
increases expression |
ISO |
Amitriptyline results in increased expression of FNDC4 mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 6:25,077,155...25,080,812
|
|
G |
Gabra1 |
gamma-aminobutyric acid type A receptor subunit alpha 1 |
increases expression decreases expression |
EXP |
Amitriptyline results in increased expression of GABRA1 mRNA Amitriptyline results in decreased expression of GABRA1 mRNA |
CTD |
PMID:21820738 PMID:22341215 |
|
NCBI chr10:27,096,731...27,152,563
|
|
G |
Gabra2 |
gamma-aminobutyric acid type A receptor subunit alpha 2 |
increases expression |
EXP |
Amitriptyline results in increased expression of GABRA2 mRNA |
CTD |
PMID:21820738 |
|
NCBI chr14:37,451,218...37,587,458
|
|
G |
Gabra4 |
gamma-aminobutyric acid type A receptor subunit alpha 4 |
increases expression |
EXP |
Amitriptyline results in increased expression of GABRA4 mRNA |
CTD |
PMID:21820738 |
|
NCBI chr14:36,590,782...36,667,724
|
|
G |
Gabrb3 |
gamma-aminobutyric acid type A receptor subunit beta 3 |
increases expression |
EXP |
Amitriptyline results in increased expression of GABRB3 mRNA |
CTD |
PMID:21820738 |
|
NCBI chr 1:117,602,772...117,838,230
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
EXP |
Amitriptyline results in increased expression of GADD45A mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 4:97,484,497...97,486,799
|
|
G |
Gal |
galanin and GMAP prepropeptide |
increases expression |
EXP |
Amitriptyline results in increased expression of GAL mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 1:210,079,709...210,084,572
|
|
G |
Gckr |
glucokinase regulator |
affects expression |
EXP |
Amitriptyline affects the expression of GCKR mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 6:25,044,592...25,075,834
|
|
G |
Gdpd3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
increases expression |
ISO |
Amitriptyline results in increased expression of GDPD3 mRNA |
CTD |
PMID:15342952 PMID:17175557 PMID:17567588 |
|
NCBI chr 1:181,373,505...181,383,063
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
EXP |
Amitriptyline results in increased expression of GFAP mRNA |
CTD |
PMID:22954530 |
|
NCBI chr10:88,352,987...88,361,661
|
|
G |
Gls2 |
glutaminase 2 |
affects expression |
EXP |
Amitriptyline affects the expression of GLS2 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 7:617,252...633,424
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
affects expression |
EXP |
Amitriptyline affects the expression of GOT2 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr19:9,180,428...9,206,113
|
|
G |
Grb14 |
growth factor receptor bound protein 14 |
affects expression |
EXP |
Amitriptyline affects the expression of GRB14 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 3:49,568,210...49,683,805
|
|
G |
Grik1 |
glutamate ionotropic receptor kainate type subunit 1 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of GRIK1 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr11:27,169,739...27,571,131
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases activity |
ISO |
Amitriptyline results in decreased activity of GSTP1 protein |
CTD |
PMID:15094841 |
|
NCBI chr 1:210,767,237...210,770,242
|
|
G |
Hal |
histidine ammonia lyase |
affects expression |
EXP |
Amitriptyline affects the expression of HAL mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 7:28,007,449...28,037,701
|
|
G |
Hmgb2 |
high mobility group box 2 |
affects expression |
EXP |
Amitriptyline affects the expression of HMGB2 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr16:37,721,374...37,723,950
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
increases expression |
ISO |
Amitriptyline results in increased expression of HMGCS1 mRNA |
CTD |
PMID:16324787 |
|
NCBI chr 2:53,379,457...53,399,807
|
|
G |
Hoxd1 |
homeo box D1 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of HOXD1 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 3:59,665,629...59,667,769
|
|
G |
Hpn |
hepsin |
increases expression |
ISO |
Amitriptyline results in increased expression of HPN mRNA |
CTD |
PMID:15342952 PMID:17175557 PMID:17567588 |
|
NCBI chr 1:86,337,085...86,352,785
|
|
G |
Hpse |
heparanase |
decreases expression |
EXP |
Amitriptyline results in decreased expression of HPSE mRNA |
CTD |
PMID:22341215 |
|
NCBI chr14:9,200,971...9,241,377
|
|
G |
Hs3st2 |
heparan sulfate-glucosamine 3-sulfotransferase 2 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of HS3ST2 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 1:175,956,161...176,077,400
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
increases expression |
EXP |
Amitriptyline results in increased expression of HTR1A protein |
CTD |
PMID:1589591 |
|
NCBI chr 2:38,427,169...38,431,733
|
|
G |
Htr1d |
5-hydroxytryptamine receptor 1D |
decreases expression |
EXP |
Amitriptyline results in decreased expression of HTR1D mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 5:153,939,735...153,960,012
|
|
G |
Htr2c |
5-hydroxytryptamine receptor 2C |
affects binding |
ISO |
Amitriptyline binds to HTR2C protein |
CTD |
PMID:18083778 |
|
NCBI chr X:115,453,190...115,682,325
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [7-ketocholesterol results in increased expression of IL1B protein]; Amitriptyline inhibits the reaction [Cholesterol analog results in increased expression of IL1B protein] |
CTD |
PMID:28633109 |
|
NCBI chr 3:137,030,200...137,036,581
|
|
G |
Il33 |
interleukin 33 |
affects expression |
EXP |
Amitriptyline affects the expression of IL33 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 1:227,701,964...227,736,374
|
|
G |
Inhbe |
inhibin subunit beta E |
increases expression |
ISO |
Amitriptyline results in increased expression of INHBE mRNA |
CTD |
PMID:15342952 PMID:17175557 PMID:17567588 |
|
NCBI chr 7:65,061,531...65,064,519
|
|
G |
Itgb6 |
integrin subunit beta 6 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of ITGB6 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 3:45,046,295...45,170,532
|
|
G |
Kcna4 |
potassium voltage-gated channel subfamily A member 4 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of KCNA4 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 3:93,756,399...93,778,004
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [KCNH2 protein results in increased transport of Thallium] |
CTD |
PMID:19583963 PMID:21158687 |
|
NCBI chr 4:11,719,357...11,751,424
|
|
G |
Kcnn2 |
potassium calcium-activated channel subfamily N member 2 |
decreases activity |
EXP |
Amitriptyline results in decreased activity of KCNN2 protein |
CTD |
PMID:10915830 |
|
NCBI chr18:40,004,693...40,445,043
|
|
G |
Kcns1 |
potassium voltage-gated channel, modifier subfamily S, member 1 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of KCNS1 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 3:152,835,642...152,843,032
|
|
G |
Kcns3 |
potassium voltage-gated channel, modifier subfamily S, member 3 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of KCNS3 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 6:33,808,314...33,865,018
|
|
G |
Lox |
lysyl oxidase |
affects expression |
EXP |
Amitriptyline affects the expression of LOX mRNA |
CTD |
PMID:18355885 |
|
NCBI chr18:45,964,544...45,977,431
|
|
G |
Lss |
lanosterol synthase |
increases expression |
ISO |
Amitriptyline results in increased expression of LSS mRNA |
CTD |
PMID:15342952 PMID:17175557 PMID:17567588 |
|
NCBI chr20:12,090,641...12,118,230
|
|
G |
Macroh2a1 |
macroH2A.1 histone |
affects expression |
EXP |
Amitriptyline affects the expression of MACROH2A1 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr17:8,479,331...8,542,071
|
|
G |
Manba |
mannosidase beta |
affects expression |
EXP |
Amitriptyline affects the expression of MANBA mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 2:223,910,432...224,002,988
|
|
G |
Maoa |
monoamine oxidase A |
affects expression |
EXP |
Amitriptyline affects the expression of MAOA mRNA |
CTD |
PMID:21820738 |
|
NCBI chr X:8,615,239...8,681,372
|
|
G |
Mlx |
MAX dimerization protein MLX |
affects expression |
EXP |
Amitriptyline affects the expression of MLX mRNA |
CTD |
PMID:18355885 |
|
NCBI chr10:86,519,517...86,524,607
|
|
G |
Mmp16 |
matrix metallopeptidase 16 |
increases expression |
EXP |
Amitriptyline results in increased expression of MMP16 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 5:31,312,280...31,556,276
|
|
G |
Mrps18b |
mitochondrial ribosomal protein S18B |
affects expression |
EXP |
Amitriptyline affects the expression of MRPS18B mRNA |
CTD |
PMID:18355885 |
|
NCBI chr20:2,842,978...2,849,065
|
|
G |
Msmo1 |
methylsterol monooxygenase 1 |
affects expression |
EXP |
Amitriptyline affects the expression of MSMO1 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr16:24,980,680...24,997,927
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [7-ketocholesterol affects the localization of NLRP3 protein]; Amitriptyline inhibits the reaction [Cholesterol analog affects the localization of NLRP3 protein] |
CTD |
PMID:28633109 |
|
NCBI chr10:44,826,299...44,853,373
|
|
G |
Nmb |
neuromedin B |
decreases expression |
EXP |
Amitriptyline results in decreased expression of NMB mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 1:134,869,446...134,875,507
|
|
G |
Nmur1 |
neuromedin U receptor 1 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of NMUR1 mRNA |
CTD |
PMID:21820738 |
|
NCBI chr 9:94,480,002...94,486,147
|
|
G |
Nog |
noggin |
decreases expression |
EXP |
Amitriptyline results in decreased expression of NOG mRNA |
CTD |
PMID:22341215 |
|
NCBI chr10:74,625,874...74,627,501
|
|
G |
Nphs2 |
NPHS2 stomatin family member, podocin |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [Homocysteine results in decreased expression of NPHS2 protein] |
CTD |
PMID:23024785 |
|
NCBI chr13:68,448,720...68,461,312
|
|
G |
Npy |
neuropeptide Y |
increases expression |
EXP |
Amitriptyline results in increased expression of NPY mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 4:80,212,111...80,219,310
|
|
G |
Npy5r |
neuropeptide Y receptor Y5 |
increases expression |
EXP |
Amitriptyline results in increased expression of NPY5R mRNA |
CTD |
PMID:21820738 |
|
NCBI chr16:23,055,427...23,063,384
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
increases expression |
ISO |
Amitriptyline results in increased expression of NR0B2 mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr 5:145,779,294...145,782,609
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
affects response to substance |
ISO |
NR3C1 protein affects the susceptibility to Amitriptyline |
CTD |
PMID:11226678 |
|
NCBI chr18:31,522,783...31,644,508
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
increases expression |
EXP |
Amitriptyline results in increased expression of NR3C2 mRNA |
CTD |
PMID:12393271 |
|
NCBI chr19:47,619,853...47,964,089
|
|
G |
Nrep |
neuronal regeneration related protein |
affects expression |
EXP |
Amitriptyline affects the expression of NREP mRNA |
CTD |
PMID:18355885 |
|
NCBI chr18:25,291,219...25,320,742
|
|
G |
Ntng1 |
netrin G1 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of NTNG1 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 2:197,462,785...197,827,681
|
|
G |
Nupr1 |
nuclear protein 1, transcriptional regulator |
increases expression |
ISO |
Amitriptyline results in increased expression of NUPR1 mRNA |
CTD |
PMID:15342952 PMID:17175557 PMID:17567588 |
|
NCBI chr 1:190,643,866...190,645,901
|
|
G |
Oaf |
out at first homolog |
affects expression |
EXP |
Amitriptyline affects the expression of OAF mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 8:43,594,362...43,612,334
|
|
G |
Patj |
PATJ, crumbs cell polarity complex component |
decreases expression |
EXP |
Amitriptyline results in decreased expression of PATJ mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 5:113,061,985...113,364,807
|
|
G |
Pc |
pyruvate carboxylase |
affects expression |
EXP |
Amitriptyline affects the expression of PC mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 1:211,228,708...211,327,792
|
|
G |
Pecr |
peroxisomal trans-2-enoyl-CoA reductase |
affects expression |
EXP |
Amitriptyline affects the expression of PECR mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 9:73,897,877...73,926,511
|
|
G |
Phyh |
phytanoyl-CoA 2-hydroxylase |
increases expression |
ISO |
Amitriptyline results in increased expression of PHYH mRNA |
CTD |
PMID:15342952 |
|
NCBI chr17:73,329,461...73,346,359
|
|
G |
Plcd4 |
phospholipase C, delta 4 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of PLCD4 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 9:76,115,523...76,158,602
|
|
G |
Plpp4 |
phospholipid phosphatase 4 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of PLPP4 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 1:183,829,794...183,959,319
|
|
G |
Por |
cytochrome p450 oxidoreductase |
affects expression |
EXP |
Amitriptyline affects the expression of POR mRNA |
CTD |
PMID:18355885 |
|
NCBI chr12:26,587,674...26,655,612
|
|
G |
Prokr1 |
prokineticin receptor 1 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of PROKR1 mRNA |
CTD |
PMID:21820738 |
|
NCBI chr 4:120,022,301...120,033,367
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [7-ketocholesterol affects the localization of PYCARD protein]; Amitriptyline inhibits the reaction [Cholesterol analog affects the localization of PYCARD protein] |
CTD |
PMID:28633109 |
|
NCBI chr 1:192,032,124...192,033,419
|
|
G |
Rasd1 |
ras related dexamethasone induced 1 |
increases expression |
EXP |
Amitriptyline results in increased expression of RASD1 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr10:45,265,975...45,275,279
|
|
G |
Rbl2 |
RB transcriptional corepressor like 2 |
affects expression |
EXP |
Amitriptyline affects the expression of RBL2 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr19:32,049,690...32,096,467
|
|
G |
Reg3b |
regenerating family member 3 beta |
increases expression |
EXP |
Amitriptyline results in increased expression of REG3B mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 4:110,861,775...110,865,015
|
|
G |
Rnf112 |
ring finger protein 112 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of RNF112 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr10:46,620,602...46,655,745
|
|
G |
RT1-Da |
RT1 class II, locus Da |
increases expression |
EXP |
Amitriptyline results in increased expression of RT1-DA mRNA |
CTD |
PMID:22341215 |
|
NCBI chr20:4,513,464...4,518,457
|
|
G |
RT1-Db1 |
RT1 class II, locus Db1 |
increases expression |
EXP |
Amitriptyline results in increased expression of RT1-DB1 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr20:4,548,664...4,558,237
|
|
G |
RT1-S3 |
RT1 class Ib, locus S3 |
affects expression |
EXP |
Amitriptyline affects the expression of RT1-S3 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr20:2,670,654...2,675,411
|
|
G |
Scd |
stearoyl-CoA desaturase |
increases expression |
ISO |
Amitriptyline results in increased expression of SCD mRNA |
CTD |
PMID:16324787 |
|
NCBI chr 1:253,218,968...253,232,101
|
|
G |
Scn11a |
sodium voltage-gated channel alpha subunit 11 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of SCN11A mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 8:119,495,550...119,567,044
|
|
G |
Sema6a |
semaphorin 6A |
increases expression |
EXP |
Amitriptyline results in increased expression of SEMA6A mRNA |
CTD |
PMID:22341215 |
|
NCBI chr18:40,050,623...40,171,954
|
|
G |
Serpina3n |
serpin family A member 3N |
increases expression |
ISO |
Amitriptyline results in increased expression of SERPINA3 mRNA |
CTD |
PMID:15342952 PMID:17175557 PMID:17567588 |
|
NCBI chr 6:123,323,623...123,331,181
|
|
G |
Sh3gl3 |
SH3 domain containing GRB2 like 3, endophilin A3 |
affects expression |
EXP |
Amitriptyline affects the expression of SH3GL3 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 1:136,124,500...136,255,669
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
multiple interactions decreases activity |
ISO |
Amitriptyline inhibits the reaction [SLC22A1 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] Amitriptyline results in decreased activity of SLC22A1 protein |
CTD |
PMID:30189235 PMID:31364238 |
|
NCBI chr 1:50,624,339...50,651,437
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions decreases activity |
ISO |
Amitriptyline inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]; Amitriptyline inhibits the reaction [SLC22A2 protein results in increased import of Tetraethylammonium]; Amitriptyline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Amitriptyline inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] Amitriptyline results in decreased activity of SLC22A2 protein |
CTD |
PMID:21599003 PMID:23770354 PMID:28629854 PMID:30189235 PMID:31364238 |
|
NCBI chr 1:50,668,817...50,711,019
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] |
CTD |
PMID:21561794 |
|
NCBI chr 1:205,522,579...205,531,179
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
decreases expression |
ISO |
Amitriptyline results in decreased expression of SLC2A3 mRNA |
CTD |
PMID:15342952 PMID:17175557 PMID:17567588 |
|
NCBI chr 4:157,632,887...157,698,034
|
|
G |
Slc47a2 |
solute carrier family 47 member 2 |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [SLC47A2 protein results in increased import of Tetraethylammonium] |
CTD |
PMID:28629854 |
|
NCBI chr10:46,490,262...46,532,954
|
|
G |
Slc6a6 |
solute carrier family 6 member 6 |
affects expression |
EXP |
Amitriptyline affects the expression of SLC6A6 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 4:124,195,186...124,268,880
|
|
G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
affects expression |
EXP |
Amitriptyline affects the expression of SLCO1A4 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 4:174,710,004...174,764,810
|
|
G |
Smagp |
small cell adhesion glycoprotein |
increases expression |
EXP |
Amitriptyline results in increased expression of SMAGP mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 7:131,720,260...131,738,711
|
|
G |
Smpd1 |
sphingomyelin phosphodiesterase 1 |
multiple interactions increases response to substance decreases activity |
ISO |
[Amitriptyline results in decreased expression of and results in decreased activity of SMPD1 protein] which results in decreased abundance of Ceramides; Amitriptyline results in decreased expression of and results in decreased activity of SMPD1 protein SMPD1 protein results in increased susceptibility to Amitriptyline Amitriptyline results in decreased activity of SMPD1 protein |
CTD |
PMID:23770692 |
|
NCBI chr 1:169,304,772...169,308,615
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression |
EXP |
Amitriptyline results in increased expression of SOD1 mRNA |
CTD |
PMID:10721683 |
|
NCBI chr11:42,942,742...42,948,399
|
|
G |
Sorl1 |
sortilin related receptor 1 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of SORL1 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 8:51,238,713...51,401,458
|
|
G |
Sox11 |
SRY-box transcription factor 11 |
increases expression |
EXP |
Amitriptyline results in increased expression of SOX11 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 6:44,008,333...44,010,354
|
|
G |
Sprr1a |
small proline-rich protein 1A |
increases expression |
EXP |
Amitriptyline results in increased expression of SPRR1A mRNA |
CTD |
PMID:22341215 |
|
NCBI chr 2:180,750,709...180,752,625
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
ISO |
Amitriptyline results in increased cleavage of and results in increased activity of SREBF1 protein |
CTD |
PMID:16324787 |
|
NCBI chr10:45,507,152...45,529,164
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
multiple interactions |
ISO |
Amitriptyline results in increased cleavage of and results in increased activity of SREBF2 protein |
CTD |
PMID:16324787 |
|
NCBI chr 7:115,542,774...115,600,945
|
|
G |
Sstr1 |
somatostatin receptor 1 |
decreases expression |
EXP |
Amitriptyline results in decreased expression of SSTR1 mRNA |
CTD |
PMID:21820738 |
|
NCBI chr 6:75,832,292...75,836,806
|
|
G |
St13 |
ST13, Hsp70 interacting protein |
affects expression |
EXP |
Amitriptyline affects the expression of ST13 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 7:114,769,758...114,805,877
|
|
G |
Stac2 |
SH3 and cysteine rich domain 2 |
increases expression |
EXP |
Amitriptyline results in increased expression of STAC2 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr10:83,032,418...83,048,260
|
|
G |
Stbd1 |
starch binding domain 1 |
affects expression |
EXP |
Amitriptyline affects the expression of STBD1 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr14:15,470,452...15,473,857
|
|
G |
Stmn1 |
stathmin 1 |
affects expression |
EXP |
Amitriptyline affects the expression of STMN1 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 5:151,964,308...151,970,843
|
|
G |
Stmn4 |
stathmin 4 |
increases expression |
EXP |
Amitriptyline results in increased expression of STMN4 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr15:40,541,305...40,559,253
|
|
G |
Tagln |
transgelin |
decreases expression |
ISO |
Amitriptyline results in decreased expression of TAGLN mRNA |
CTD |
PMID:15342952 PMID:17175557 PMID:17567588 |
|
NCBI chr 8:55,121,647...55,127,121
|
|
G |
Tex261 |
testis expressed 261 |
affects expression |
EXP |
Amitriptyline affects the expression of TEX261 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 4:116,253,547...116,260,730
|
|
G |
Tgm1 |
transglutaminase 1 |
increases expression |
EXP |
Amitriptyline results in increased expression of TGM1 mRNA |
CTD |
PMID:22341215 |
|
NCBI chr15:29,191,039...29,206,000
|
|
G |
Timm10b |
translocase of inner mitochondrial membrane 10B |
affects expression |
EXP |
Amitriptyline affects the expression of TIMM10B mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 1:169,392,355...169,395,201
|
|
G |
Trh |
thyrotropin releasing hormone |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [TRH protein results in decreased expression of TSHB protein] |
CTD |
PMID:6455462 |
|
NCBI chr 4:124,742,111...124,777,094
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
multiple interactions |
EXP |
Amitriptyline inhibits the reaction [[Capsaicin results in increased activity of TRPV1 protein] which results in increased uptake of Calcium] |
CTD |
PMID:23264033 |
|
NCBI chr10:58,349,936...58,375,021
|
|
G |
Tshb |
thyroid stimulating hormone subunit beta |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [TRH protein results in decreased expression of TSHB protein] |
CTD |
PMID:6455462 |
|
NCBI chr 2:190,224,676...190,229,559
|
|
G |
Uba52 |
ubiquitin A-52 residue ribosomal protein fusion product 1 |
affects expression |
EXP |
Amitriptyline affects the expression of UBA52 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr16:18,952,583...18,954,780
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
affects expression |
EXP |
Amitriptyline affects the expression of UGT1A1 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr 9:96,249,143...96,256,264
|
|
G |
Ugt2a1 |
UDP glucuronosyltransferase family 2 member A1 |
affects expression |
EXP |
Amitriptyline affects the expression of UGT2A1 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr14:20,521,018...20,545,934
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
affects expression |
EXP |
Amitriptyline affects the expression of UGT2B1 mRNA |
CTD |
PMID:18355885 |
|
NCBI chr14:21,378,882...21,390,631
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
Amitriptyline inhibits the reaction [Homocysteine results in decreased secretion of VEGFA protein] |
CTD |
PMID:23024785 |
|
NCBI chr 9:22,452,854...22,468,194
|
|
G |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
increases expression |
ISO |
Amitriptyline results in increased expression of WIPI1 mRNA |
CTD |
PMID:15342952 PMID:17175557 |
|
NCBI chr10:95,042,451...95,079,679
|
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
cyclobenzaprine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:50,668,817...50,711,019
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases transport affects response to substance |
ISO |
ABCB1A protein results in increased transport of Nortriptyline; ABCB1A protein results in increased transport of Nortriptyline metabolite ABCB1 exon SNP affects the susceptibility to Nortriptyline |
CTD |
PMID:10700657 PMID:12082591 |
|
NCBI chr 4:26,312,403...26,488,456
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases activity |
ISO |
Nortriptyline results in decreased activity of ABCB4 protein |
CTD |
PMID:28437613 |
|
NCBI chr 4:26,106,895...26,164,440
|
|
G |
Casp3 |
caspase 3 |
decreases activity increases activity multiple interactions |
ISO |
Nortriptyline results in decreased activity of CASP3 protein Nortriptyline results in increased activity of CASP3 protein Palmitic Acid promotes the reaction [Nortriptyline results in increased activity of CASP3 protein] |
CTD |
PMID:17686041 PMID:18174477 PMID:22700542 |
|
NCBI chr16:52,395,539...52,413,794
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases activity |
ISO |
Palmitic Acid promotes the reaction [Nortriptyline results in increased activity of CASP7 protein] |
CTD |
PMID:22700542 |
|
NCBI chr 1:265,442,647...265,481,938
|
|
G |
Cycs |
cytochrome c, somatic |
decreases secretion |
ISO |
Nortriptyline results in decreased secretion of CYCS protein |
CTD |
PMID:17686041 |
|
NCBI chr 4:80,982,667...80,984,767
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases metabolic processing |
ISO |
Nortriptyline results in increased metabolism of CYP1A2 protein |
CTD |
PMID:18359012 |
|
NCBI chr 8:66,971,261...66,978,149
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
decreases activity multiple interactions |
ISO |
Nortriptyline results in decreased activity of CYP2C8 protein torsemide inhibits the reaction [Nortriptyline results in decreased activity of CYP2C8 protein] |
CTD |
PMID:15304522 |
|
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases response to substance multiple interactions increases metabolic processing increases hydroxylation |
ISO |
CYP2D6 gene mutant form results in decreased susceptibility to Nortriptyline Paroxetine inhibits the reaction [CYP2D6 gene mutant form results in decreased susceptibility to Nortriptyline] Nortriptyline results in increased metabolism of CYP2D6 protein CYP2D6 protein results in increased hydroxylation of Nortriptyline |
CTD |
PMID:11673748 PMID:17470523 PMID:18359012 |
|
NCBI chr 7:115,762,662...115,771,832
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing |
ISO |
Nortriptyline results in increased metabolism of CYP3A4 protein |
CTD |
PMID:18359012 |
|
NCBI chr12:14,321,771...14,343,886
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases metabolic processing |
ISO |
Nortriptyline results in increased metabolism of CYP3A5 protein |
CTD |
PMID:18359012 |
|
NCBI chr12:21,919,955...21,960,160
|
|
G |
Gnb3 |
G protein subunit beta 3 |
decreases response to substance increases response to substance |
ISO |
GNB3 gene polymorphism results in decreased susceptibility to Nortriptyline GNB3 protein results in increased susceptibility to Nortriptyline |
CTD |
PMID:14604448 |
|
NCBI chr 4:157,639,468...157,645,171
|
|
G |
Htr2c |
5-hydroxytryptamine receptor 2C |
decreases expression |
ISO |
Nortriptyline results in decreased expression of HTR2C protein |
CTD |
PMID:8131152 |
|
NCBI chr X:115,453,190...115,682,325
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Nortriptyline |
CTD |
PMID:19362101 |
|
NCBI chr 3:136,979,804...136,990,236
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Nortriptyline |
CTD |
PMID:19362101 |
|
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions |
ISO |
Nortriptyline inhibits the reaction [KCNH2 protein results in increased transport of Thallium] |
CTD |
PMID:21158687 |
|
NCBI chr 4:11,719,357...11,751,424
|
|
G |
Pf4 |
platelet factor 4 |
affects expression |
ISO |
Nortriptyline affects the expression of PF4 protein |
CTD |
PMID:10770450 |
|
NCBI chr14:17,582,477...17,583,392
|
|
G |
Ppbp |
pro-platelet basic protein |
affects expression |
ISO |
Nortriptyline affects the expression of PPBP protein |
CTD |
PMID:10770450 |
|
NCBI chr14:17,586,495...17,587,299
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Nortriptyline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:50,668,817...50,711,019
|
|
G |
Slc6a2 |
solute carrier family 6 member 2 |
affects response to substance |
ISO |
SLC6A2 gene polymorphism affects the susceptibility to Nortriptyline |
CTD |
PMID:17018806 |
|
NCBI chr19:30,183,289...30,228,292
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
affects response to substance increases response to substance decreases response to substance |
ISO |
SLC6A4 polymorphism affects the susceptibility to Nortriptyline; SLC6A4 promoter polymorphism affects the susceptibility to Nortriptyline SLC6A4 protein results in increased susceptibility to Nortriptyline SLC6A4 gene polymorphism results in decreased susceptibility to Nortriptyline |
CTD |
PMID:14604448 PMID:17018806 PMID:21658141 |
|
NCBI chr10:62,322,688...62,357,060
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Nortriptyline |
CTD |
PMID:19362101 |
|
NCBI chr20:3,626,685...3,629,303
|
|
|
G |
Abcb4 |
ATP binding cassette subfamily B member 4 |
decreases activity |
ISO |
Protriptyline results in decreased activity of ABCB4 protein |
CTD |
PMID:28437613 |
|
NCBI chr 4:26,106,895...26,164,440
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
increases expression |
ISO |
Protriptyline results in increased expression of BMP6 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr17:26,523,704...26,785,558
|
|
G |
Ereg |
epiregulin |
increases expression |
ISO |
Protriptyline results in increased expression of EREG mRNA |
CTD |
PMID:32816093 |
|
NCBI chr14:17,311,485...17,325,260
|
|
G |
Il24 |
interleukin 24 |
increases expression |
ISO |
Protriptyline results in increased expression of IL24 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr13:44,905,362...44,910,760
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
increases expression |
ISO |
Protriptyline results in increased expression of MET mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 4:46,756,823...46,864,041
|
|
G |
Pid1 |
phosphotyrosine interaction domain containing 1 |
increases expression |
ISO |
Protriptyline results in increased expression of PID1 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 9:85,284,335...85,503,035
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
ISO |
Protriptyline results in increased expression of PTGS2 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr13:64,714,063...64,722,320
|
|
G |
Slc6a2 |
solute carrier family 6 member 2 |
decreases expression |
ISO |
Protriptyline results in decreased expression of SLC6A2 protein |
CTD |
PMID:18923402 |
|
NCBI chr19:30,183,289...30,228,292
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
decreases expression |
ISO |
Protriptyline results in decreased expression of SLC7A11 mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 2:136,532,912...136,668,560
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
increases expression |
ISO |
Protriptyline results in increased expression of SLPI mRNA |
CTD |
PMID:32816093 |
|
NCBI chr 3:173,501,573...173,503,822
|
|